CClinicalTrials.gg
Status unknownNCT02987101Updated Dec 8, 2016

Treatment of Chronic Leg Ulcers With Autologous Stromal Vascular Fraction

An interventional study of Liposuction and Standard wound care in Leg Ulcer, sponsored by Odense University Hospital. Status unknown at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-12-08.

Sponsored by Odense University Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Chronic leg ulcers are associated with decreased quality of life and an increased mortality. In many cases these ulcers are treated conservatively and the healing time can be several months. In this open randomized clinical trial we will examine if we can accelerate wound healing when using autologous stromal vascular fraction as an adjunct to standard wound care.

Read the detailed description

Chronic leg ulcers are associated with decreased quality of life and an increased mortality. In many cases these ulcers are treated conservatively and the healing time can be several months. In this open randomized clinical trial we will examine if we can accelerate wound healing when using autologous stromal vascular fraction (SVF) as an adjunct to standard wound care.

The plan is to include 30 patients with arterial or arteriovenous chronic leg ulcers and these are randomized in two groups of which one receives standard wound care only and the other group receives autologous stromal vascular fraction treatment in addition to standard wound care.

02

Conditions studied

  • Leg Ulcer

Browse trials for

03

In context

Leg Ulcer

298 studies on the registry are indexed under Leg Ulcer; 43 are open to participants now.

This study's planned enrollment of 30 is below the median of 60 across 241 interventional studies indexed under Leg Ulcer.

Browse Leg Ulcer studies →

Lead sponsor

Odense University Hospital is the lead sponsor of 468 studies on the registry; 109 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Arteriovenous chronic leg ulcer
  • Present beyond 4 months
  • Conservative treatment not leading to progress
  • Wound size between 2-30cm2
  • ankle-brachial index (ABI) ( 50-90% and/or toe pressure 50-70% and where ankle pressure > 60 mmHg or toe pressure > 40 mmHg
  • Written informed consent

Exclusion criteria

Exclusion Criteria:

  • Uncontrolled wound infection
  • Osteomyelitis
  • Hemoglobin \<6.0mmol/L
  • HbA1c >80mmol/mol
  • Underlying malignancy
  • Pregnancy or lactating
  • Renal insufficiency requiring dialysis
  • Charcot foot
  • Underlying malignancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Autologous SVF + Standard of care

    local injection around and under wound with autologous stromal vascular fraction. Standard wound care is given independent of this study.

    Procedure: Liposuction · Other: Standard wound care · Drug: Adipose-Derived Regenerative Cells

  • Other
    Standard of care

    Standard wound care is given independent of this study.

    Other: Standard wound care

Interventions

  • ProcedureLiposuction

    Adipose tissue is harvested by liposuction from either abdomen or thighs.

  • OtherStandard wound care

    Patients will receive standard wound care and dressings independent of their participation in this study at the discretion of the wound nurses.

  • DrugAdipose-Derived Regenerative Cells

    Cells isolated from adipose-derived tissue will be injected locally around and under the wound.

06

What researchers measure

Primary outcomes

  1. Change in wound size

    Photography is taken every 2 weeks until complete wound healing. Final follow-up date regardless of complete wound healing or not is 6 months.

    Time frame: 6 months

Secondary outcomes

  1. Distal blood pressure measurement

    Change in distal blood pressure measurement before and 6 months after treatment

    Time frame: 6 months

  2. Transcutaneous oxygen tension

    Change in transcutaneous oxygen tension around the wound before and 6 months after treatment.

    Time frame: 6 months

  3. Treatment-related adverse events

    Monitoring of any side effects or complications related to intervention

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Odense University Hospital
    Odense, 5000, Denmark
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02987101
Lead sponsor
Odense University Hospital
Responsible party
Navid Toyserkani (Resident, PhD fellow, MD, Odense University Hospital) — Principal investigator
First posted
Dec 8, 2016
Start date
Nov 2016
Primary completion
Jun 2018 (estimated)
Completion
Jun 2018 (estimated)
Last update
Dec 8, 2016

Study contacts

Navid M Toyserkani, MD
Contact
navid.m.toyserkani@rsyd.dk
+4550383833
Jens A Sørensen, MD PhD
study chair · Dept. Plastic Surgery, OUH, Consultant, Professor

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion